Reston Wealth Management’s AbbVie ABBV Stock Holding History

Reston Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	1,490 +9	+0.6%	+$1.94K	0.1%	45
2026 Q1	$322K	Sell	1,481 -256	-15%	-$56.8K	0.1%	47
2025 Q4	$397K	Buy	1,737 +266	+18%	+$60.6K	0.12%	36
2025 Q3	$341K	Buy	1,471 +49	+3%	+$9.98K	0.11%	37
2025 Q2	$264K	Sell	1,422 -151	-10%	-$28.1K	0.09%	42
2025 Q1	$330K	Buy	1,573 +179	+13%	+$34.8K	0.13%	35
2024 Q4	$248K	Sell	1,394 -18	-1%	-$3.31K	0.09%	44
2024 Q3	$279K	Buy	1,412 +10	+0.7%	+$1.87K	0.1%	43
2024 Q2	$241K	Sell	1,402 -38	-3%	-$6.29K	0.1%	44
2024 Q1	$262K	Sell	1,440 -87	-6%	-$15K	0.11%	45
2023 Q4	$237K	Buy	+1,527	New	+$223K	0.11%	47
2022 Q3	–	Sell	-1,514	Closed	-$232K	–	49
2022 Q2	$232K	Buy	1,514 +5	+0.3%	+$764	0.13%	53
2022 Q1	$245K	Buy	1,509 +28	+2%	+$4.07K	0.13%	48
2021 Q4	$201K	Buy	+1,481	New	+$175K	0.1%	62

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Reston Wealth Management's ABBV Position: Q2 2026 in Review

Reston Wealth Management increased its AbbVie (ABBV) stake by 0.61% in Q2 2026, buying an estimated $1.94K and bringing the position to 1,490 shares worth $375K. The position accounts for 0.1% of the portfolio, ranked #45.

Reston Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 14 quarters since. The position peaked at $397K in Q4 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Reston Wealth Management held 1,490 shares of AbbVie worth $375K as of Q2 2026.
Reston Wealth Management bought 9 AbbVie shares in Q2 2026, an estimated $1.94K.
AbbVie made up 0.1% of Reston Wealth Management's portfolio in Q2 2026, its #45 holding.
Reston Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 14 quarters since.
Reston Wealth Management's AbbVie position peaked at $397K in Q4 2025.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Reston Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.